The Blue Toe Syndrome during Oral Anticoagulant Therapy with Acenocoumarol

M.A. Fernández; R. Andreu; J. M. Fortea; J. Aznar

doi:10.1055/s-0037-1615662

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2001; 85(04): 743
DOI: 10.1055/s-0037-1615662

Letters to the Editor

Schattauer GmbH

The Blue Toe Syndrome during Oral Anticoagulant Therapy with Acenocoumarol

M.A. Fernández

¹Unit of Anticoagulant Therapy, Department of Clinical Pathology, Unversity Hospital “La Fe”, Department of Dermaatology, General Hospital Valencia, Spain

,

R. Andreu

¹Unit of Anticoagulant Therapy, Department of Clinical Pathology, Unversity Hospital “La Fe”, Department of Dermaatology, General Hospital Valencia, Spain

,

J. M. Fortea

¹Unit of Anticoagulant Therapy, Department of Clinical Pathology, Unversity Hospital “La Fe”, Department of Dermaatology, General Hospital Valencia, Spain

,

J. Aznar

¹Unit of Anticoagulant Therapy, Department of Clinical Pathology, Unversity Hospital “La Fe”, Department of Dermaatology, General Hospital Valencia, Spain

References
1 Karmody AM, Powers SR, Monaco VJ, Leather RP. “Blue toe” syndrome: an indication for limb salvage surgery. Arch Surg 1976; 111: 1263-8.
2 Feder W, Auerbach R. “Purple toes”: an uncommon sequela of oral coumarin drug therapy. Ann Intern Med 1961; 55: 91-7.
3 O’Keeffe ST, Woods BO, Breslin DJ, Tsapatsaris NP. Blue toe syndrome. Arch Intern Med 1992; 152: 2197-202.
4 Sallah S, Thomas DP, Robers HR. Warfarin and Heparin-Induced Skin Necrosis and the Purple Toe Sydrome: Infrequent Complications of Anticoagulant Treatment. Thromb Haemost 1997; 78: 785-90.
5 Brewer ML, Kinnison ML, Perler BA, White RI. Blue Toe Syndrome: Treatment with Anticoagulants and Delayed Percutaneous Transluminal Angioplasty. Radiology 1988; 166: 31-6.